Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

NEW YORK , May 2, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ: TLRY).  Such investors are advised to contact Robert S.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tilray Brands, Inc. - TLRY

Canopy Growth

Compass

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

WM Technology

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

Cantor Fitzgerald said Friday it will no longer provide research coverage of 23 cannabis stocks because analyst Pablo Zuanic has departed the firm. Zuanic is now head of Zuanic & Associates, a consulting and research firm aimed at the cannabis sector, according to his LinkedIn profile and a website for the firm.

Cantor Fitzgerald discontinues cannabis stock coverage with analyst departure

Aurora Cannabis

Are Canadian Pot Stocks A Buy At Current Levels? The post Best Canadian Cannabis Stocks To Watch In May 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Cannabis Stocks To Watch In May 2023

Reintroduction of SAFE Banking Act could be the first meaningful step toward legalizing cannabis. TLRY already has relationships with distributors in the US thanks to its alcohol operations.

Tilray Brands: Cannabis Legalization Could Be Sooner Than Expected

Tilray Brands and Curaleaf Holdings shares both climbed nearly 10% on Thursday after a group of bipartisan US Congress members reintroduced the Secure and Fair Enforcement (SAFE) Banking Act in the House and Senate. The proposal would ensure that legal cannabis businesses have access to critical banking and financial services.

Tilray Brands, Curaleaf shares lead cannabis stocks higher as SAFE Banking Act reintroduced

Akebia Therapeutics

Applied Therapeutics Inc

Oatly

Analysts say these could be penny stocks to buy. Do you agree with their outlook?

4 Top Penny Stocks To Buy According To Analysts, Targets Up To 695%

The Canadian cannabis industry has some interesting long-term investment options. Aurora Cannabis could be heading for another reverse stock split.

Better Growth Stock: Aurora Cannabis vs. Tilray Brands

Cronos Group

The AdvisorShares Pure U.S. Cannabis ETF MSOS is rallying 16.5% and the ETFMG Alternative Harvest ETF MJ is up by 6% after lawmakers late Wednesday re-introduced the SAFE Banking measure to open up the financial system to legal cannabis companies. The measure has passed the House seven times but has yet to win Senate approval.

Pot stocks rally as lawmakers re-introduce SAFE Banking bill to open up financial system to legal cannabis companies

OrganiGram Holdings Inc.

Top 2 Marijuana Stocks For Investing In Legal Cannabis The post 2 Marijuana Stocks To Buy In Todays Stock Market? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Marijuana Stocks To Buy In Todays Stock Market?

American Shared Hospital Services

Solid Power

Enel Chile

Ammo

Uranium Energy

As 2023 unfolds into a promising, positive year, investors are looking to load up on the next big opportunity. The consensus amongst the market punditry is that value and reasonably priced stocks with company-specific catalysts are likely to thrive in the current economic environment.

The 7 Most Compelling Penny Stocks to Watch Right Now

The cannabis investment bonanza of 2021 may have come and gone, but there's still evidence that traders are bullish on the sector's upside, according to a report from New Frontier Data. In 2021, the cannabis industry saw more than $12 billion in investments, but in 2022 that figure was just $4 billion.

Cannabis investments shrunk in 2022, but less green didn't mean investors stopped finding value: report

SNDL Inc.

Are These Canadian Pot Stocks On Your 420 Watchlist? The post Best Canadian Marijuana Stocks For 420 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Marijuana Stocks For 420

It continues to be a long wait for the cannabis industry towards federal level legalization. It was recently reported that Democrat and Republican congressional representatives will file a bill to prepare for legalization.

3 Cannabis Stocks That Could 10X in a Legalization Scenario

Tomorrow, 'only' in states where it's legal, cannabis will be celebrated as part of the long-fabled 4/20 (April 20) holiday.

4 Cannabis Stocks to Watch Right Now

Tilray's 2023 fiscal third-quarter revenue dipped 4% to $145 million. But the company reported the 16th consecutive quarter of positive adjusted EBITDA.

Is It Too Late to Buy Tilray Stock?

Enjoy a Blast of Summer Nostalgia with Good Supply's New Product Lineup Now Available Across Canada Enjoy a Blast of Summer Nostalgia with Good Supply's New Product Lineup Now Available Across Canada

Celebrate 420 with Good Supply!

Scotts Miracle-Gro

Village Farms International

Here are seven steps to investing in the high-flying cannabis industry.

7 Steps to Investing in Marijuana Stocks

NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that its U.S. Beer division consisting of SweetWater Brewing Company, Alpine Beer, Green Flash Brewing, and Montauk Brewing Company, is now number nine on the Brewers Association 2022 annual report of top 50 craft brewing companies in the U.S., based on beer sales volume. The Brewers Association, the trade association representing American craft brewers, released its annual production figures for the U.S. craft brewing industry naming the largest fifty out of 9,553 total operating craft breweries in the U.S.

Tilray Brands Ranks on the Brewers Association List of Top Producing Craft Brewers in the United States

Tilray isn't a stock that's right for most investors to buy right now. If it can evolve its business to be more like InBev's, it'll be closer to being a buy.

3 Changes Tilray Must Make to Ever Be Worth Buying

Montauk Brewing Invites Fans to Celebrate 4/20 at the Brew Barn in Montauk, New York Montauk Brewing Invites Fans to Celebrate 4/20 at the Brew Barn in Montauk, New York

Montauk Brewing Company Launches PROJECT 4:20, a New Limited Release Craft Brew Supporting Local Green Charities

Tilray just purchased another Canadian marijuana business. The purchase will shore up its share of the Canadian market, which is sagging.

Here's Why Tilray's Big News Just Means More of the Same for Investors

Tilray recently reported another underwhelming earnings report, which highlighted many risks associated with its business. The company also announced plans to buy Hexo.

4 Reasons to Stay Far Away From Tilray Brands Stock

HEXO Corp

Tilray Acquires HEXO On The Cheap In Surprise Move

So, it's settled: Canadian cannabis producer Tilray (NASDAQ: TLRY ) plans to acquire rival Hexo (NASDAQ: HEXO ). It's debatable, however, whether this is actually a good idea.

Is Tilray Stock a Buy or Sell? Here's My Call.

Analysts at Canaccord Genuity (TSX:CF, LSE:CF) have lowered their price target for Tilray Brands after the company announced it is acquiring its strategic partner HEXO for US$56 million in tandem with the release of its fiscal 3Q 2023 results earlier this week. In a note to clients, the analysts wrote that their updated price target was US$4.25, down from US$5, with a ‘Buy' rating.

News for Tilray Brands Stock (TLRY)